Crispr Therapeutics AG
Ownership
Ownership Structure
Who owns Crispr Therapeutics AG (CRSP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.6% of the shares are freely tradable; institutional investors hold 79.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Investment Management LLC | 11.70 | 11,313,623 | +7.5 | 03/31/2026 |
| BlackRock Inc | 7.94 | 7,680,073 | +2.3 | 03/31/2026 |
| Orbis Allan Gray Ltd | 6.31 | 6,106,011 | +2.6 | 03/31/2026 |
| Capital World Investors | 4.91 | 4,749,525 | +0.5 | 06/30/2026 |
| State Street Corp | 4.12 | 3,982,500 | +6.1 | 03/31/2026 |
| GSK PLC | 3.33 | 3,220,627 | +0.0 | 03/31/2026 |
| T. Rowe Price Investment Management,Inc. | 3.05 | 2,952,595 | -41.8 | 03/31/2026 |
| Geode Capital Management, LLC | 2.46 | 2,377,164 | +5.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 6.03 | 5,833,283 | -20.4 | 06/30/2026 |
| ARK Innovation ETF | 5.46 | 5,283,375 | -0.9 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Prasad Raju | Chief Financial Officer | 14,815 | 848,900 $ | Aug 7, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Prasad Raju | Chief Financial Officer | Other | 750 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.